证券日报网讯 8月12日晚间，国光股份发布公告称，近日，公司、子公司国光园林、国光农资收到与兴 业银行成都分行签订的《兴业银行企业金融人民币结构性存款协议书》，公司、国光园林、国光农资使 用闲置自有资金人民币13，000万元（其中公司5，000万元，国光园林5，000万元，国光农资3，000万 元）购买了保本浮动收益型"兴业银行企业金融人民币结构性存款"。截至2025年8月12日，公司在过去 十二个月内使用闲置自有资金和闲置募集资金累计购买理财产品人民币合计144，000万元（含本次购买 的13，000万元），其中，已到期的理财产品人民币合计121，000万元。 （编辑 李家琪） ...

Core Viewpoint - The company, Aorite Pharmaceutical Co., Ltd., is utilizing part of its idle raised funds for cash management to enhance fund efficiency and generate returns while ensuring that it does not affect the construction of fundraising projects and the use of raised funds [1][3][8] Summary by Sections Cash Management Overview - Cash management trustee: Industrial Bank Co., Ltd. Taizhou Linhai Branch [1] - Investment type: Structured deposits [1] - Cash management amount: 40 million yuan [1] - Cash management duration: 30 days [1] - The company has approved the use of idle raised funds up to 300 million yuan for cash management, valid for 12 months from the board meeting date [1][6] Cash Management Redemption Situation - The product duration was 55 days, with an investment of 40 million yuan starting from May 6, 2025, and maturing on June 30, 2025 [2] - The company redeemed the principal of 40 million yuan and received a return of 123,561.64 yuan, which met expectations [2] Purpose of Cash Management - The purpose is to improve the efficiency of raised funds, reduce financial costs, and increase returns for the company and its shareholders [3][8] Source of Funds - The company issued convertible bonds totaling 812.12 million yuan, with a net amount of 800.47 million yuan after deducting issuance costs [3] Investment Product Details - The structured deposit was purchased from Industrial Bank, with a principal amount of 40 million yuan [5] - Expected annualized return rates are 1.00% or 1.90% [5] Impact on the Company - The cash management will not affect the company's fundraising project construction and main business operations, allowing for better fund utilization and investment returns [7][8]

| 证券代码: | 002335 | 证券简称: 科华数据 | 公告编号：2025-005 | | --- | --- | --- | --- | | 债券代码: | 127091 | 债券简称: 科数转债 | | 科华数据股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及其董事、监事、高级管理人员保证公告内容真实、准确和完整，没有 虚假记载、误导性陈述或者重大遗漏。 科华数据股份有限公司（以下简称"科华数据"或"公司"） 2024 年 8 月 29 日召开第九届董事会第十八次会议和第九届监事会第十次会议，审议通过了《关于 使用部分闲置募集资金进行现金管理的议案》，同意公司及子公司厦门科华慧云科 技有限公司（以下简称"科华慧云"）使用不超过人民币 4 亿元的闲置募集资金进 行现金管理，购买安全性高、流动性好，满足保本要求的产品。投资产品的期限自 本次董事会审议通过之日起不超过 12 个月且上述资金额度在决议有效期内可滚动 使用。具体内容详见公司 2024 年 8 月 30 日披露于指定信息披露媒体和巨潮资讯 网（http://www.cninfo.com.cn）的《关于使用部分闲置募集资金 ...